-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

New Strategies for Mismatched Unrelated Donors

Program: Education Program
Session: Are Alternative Donors Now Mainstream in Allogeneic Transplant?
Hematology Disease Topics & Pathways:
Research, clinical trials, Lymphoid Leukemias, Acute Myeloid Malignancies, Clinical Practice (Health Services and Quality), Lymphomas, Workforce, Clinical Research, Plasma Cell Disorders, Diversity, Equity, and Inclusion (DEI) , health disparities research, Chronic Myeloid Malignancies, Diseases, real-world evidence, registries, Lymphoid Malignancies, Myeloid Malignancies
Saturday, December 10, 2022, 4:00 PM-5:15 PM

Monzr M. Al Malki, MD

Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA

Disclosures: Al Malki: NexImmune: Consultancy, Research Funding; Hasna Biopharma: Membership on an entity's Board of Directors or advisory committees; Gilead: Consultancy, Research Funding; Miltenyi Biotec: Consultancy, Research Funding; Incyte: Consultancy, Research Funding; CareDx: Consultancy, Research Funding.

Previous Presentation | Next Presentation >>